Related Experiment Video

Updated: Jun 23, 2026

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

Percutaneous treatment of idiopathic chylopericardium

Hans H Schild1, Birgit Simon, Christiane K Kuhl

  • 1Department of Radiology, University Hospital Bonn, Bonn, Germany. schild@uni-bonn.de

Journal of Vascular and Interventional Radiology : JVIR
|April 28, 2009
PubMed

Insights

Idiopathic chylopericardium, a rare condition, was treated with percutaneous thoracic duct occlusion. While reducing fluid, this intervention did not prevent constrictive pericarditis, necessitating further surgery.

Area of Science:

  • Cardiology
  • Interventional Radiology
  • Thoracic Surgery

Background:

  • Chylopericardium is a rare condition with diverse etiologies, including surgery, trauma, or thoracic duct obstruction.
  • Idiopathic chylopericardium presents without a clear underlying cause, posing diagnostic and therapeutic challenges.

Observation:

  • A case of idiopathic chylopericardium is presented, focusing on a percutaneous transabdominal occlusion of the thoracic duct.
  • This minimally invasive approach was explored as an alternative to traditional surgical duct ligation.

Findings:

  • Percutaneous thoracic duct occlusion successfully reduced pericardial fluid accumulation in the short term.
  • The procedure did not resolve the underlying condition, as constrictive pericarditis developed two months post-intervention.

Implications:

  • Percutaneous thoracic duct occlusion may offer a temporary solution for chylopericardium but does not preclude long-term complications.
  • The development of constrictive pericarditis highlights the complexity of managing chylopericardium and suggests potential benefits of early pericardial intervention.

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...